Huadong Medicine Co Ltd (000963) — Cash Flow-to-Debt Ratio
Huadong Medicine Co Ltd (000963) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥155.98 Million could theoretically repay 0% of its total liabilities (CN¥15.43 Billion) in one year. See how much free cash does Huadong Medicine Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Huadong Medicine Co Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Huadong Medicine Co Ltd across 27 annual periods. Also explore 000963 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Huadong Medicine Co Ltd (1998–2024)
Year-by-year debt coverage analysis for Huadong Medicine Co Ltd. For market capitalisation and broader financial context, see Huadong Medicine Co Ltd (000963) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.26x | CN¥3.75 Billion | CN¥14.32 Billion | ▼ -20.5% |
| 2023 | 0.33x | CN¥3.93 Billion | CN¥11.93 Billion | ▲ +66.2% |
| 2022 | 0.20x | CN¥2.38 Billion | CN¥12.02 Billion | ▼ -37.1% |
| 2021 | 0.32x | CN¥3.17 Billion | CN¥10.06 Billion | ▼ -16.6% |
| 2020 | 0.38x | CN¥3.41 Billion | CN¥9.02 Billion | ▲ +62.4% |
| 2019 | 0.23x | CN¥2.00 Billion | CN¥8.60 Billion | ▲ +0.4% |
| 2018 | 0.23x | CN¥2.04 Billion | CN¥8.79 Billion | ▲ +0.2% |
| 2017 | 0.23x | CN¥1.66 Billion | CN¥7.18 Billion | ▲ +17.1% |
| 2016 | 0.20x | CN¥1.35 Billion | CN¥6.81 Billion | ▲ +145.3% |
| 2015 | 0.08x | CN¥658.54 Million | CN¥8.17 Billion | ▼ -29.4% |
| 2014 | 0.11x | CN¥740.85 Million | CN¥6.49 Billion | ▲ +11.5% |
| 2013 | 0.10x | CN¥476.98 Million | CN¥4.66 Billion | ▼ -33.1% |
| 2012 | 0.15x | CN¥642.73 Million | CN¥4.20 Billion | ▲ +3746.2% |
| 2011 | 0.00x | CN¥16.12 Million | CN¥4.05 Billion | ▲ +141.4% |
| 2010 | -0.01x | CN¥-27.99 Million | CN¥2.91 Billion | ▼ -103.9% |
| 2009 | 0.25x | CN¥567.94 Million | CN¥2.27 Billion | ▲ +59.3% |
| 2008 | 0.16x | CN¥344.69 Million | CN¥2.20 Billion | ▲ +7.2% |
| 2007 | 0.15x | CN¥265.79 Million | CN¥1.82 Billion | ▲ +307.0% |
| 2006 | 0.04x | CN¥57.38 Million | CN¥1.60 Billion | ▼ -75.8% |
| 2005 | 0.15x | CN¥203.33 Million | CN¥1.37 Billion | ▲ +1231.7% |
| 2004 | 0.01x | CN¥12.51 Million | CN¥1.12 Billion | ▼ -90.2% |
| 2003 | 0.11x | CN¥90.54 Million | CN¥797.04 Million | ▲ +262.0% |
| 2002 | 0.03x | CN¥23.94 Million | CN¥763.14 Million | ▼ -81.0% |
| 2001 | 0.17x | CN¥109.67 Million | CN¥663.14 Million | ▲ +429.4% |
| 2000 | 0.03x | CN¥19.59 Million | CN¥627.09 Million | ▼ -72.2% |
| 1999 | 0.11x | CN¥56.32 Million | CN¥501.93 Million | ▲ +119.9% |
| 1998 | 0.05x | CN¥23.80 Million | CN¥466.47 Million | — |